Platelet-Rich Plasma for Cutaneous Wound Healing: Clinical Outcomes Across Wound Etiologies
Plättchenreiches Plasma für die kutane Wundheilung: klinische Ergebnisse nach Wundätiologie
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s819
DOI: 10.25251/0mchk561 ↗Auf einen Blick
Die Übersichtsarbeit beschreibt klinische Heilungsergebnisse von plättchenreichem Plasma (PRP) bei verschiedenen kutanen Wundätiologien. Am konsistentesten waren die Effekte bei chronischen Ulzera, besonders beim diabetischen Fußulkus.
Fragestellung
Welche klinischen Heilungsergebnisse werden für PRP bei verschiedenen kutanen Wundätiologien berichtet?
Methode
Literaturrecherche in PubMed, Embase und SCOPUS (2020-2026); eingeschlossen wurden klinische Studien und Reviews zu PRP bei kutanen Wunden.
Ergebnisse
PRP verbesserte bei chronischen kutanen Wunden Wundverschluss und Wundflächenreduktion gegenüber Standardversorgung. Bei gemischten chronischen Wunden zeigte eine Metaanalyse mehr vollständige Heilungen; OR 5,32 in 2.198 Wunden.
Einschränkungen
Heterogenität bei PRP-Präparation, Dosis, Applikation und Outcome-Bericht erschwert die Standardisierung.
Schlussfolgerung der Autor:innen
PRP zeigt Potenzial als regenerative Zusatztherapie bei mehreren kutanen Wundätiologien, am konsistentesten bei chronischen Ulzera, besonders DFUs.
Kernaussagen
- Am konsistentesten war der Nutzen bei chronischen Ulzera, besonders DFUs
- Wundverschluss, Wundflächenreduktion und Heilungszeit verbesserten sich am häufigsten
- Heterogene PRP-Protokolle erschweren die klinische Anwendung
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Christopher Mendez und 9 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Platelet-rich plasma (PRP) is an autologous biologic therapy containing concentrated platelets and growth factors involved in angiogenesis, inflammation modulation, extracellular matrix remodeling, and re-epithelialization. Although researchers have investigated PRP across multiple wound types, differences in wound etiology, PRP formulation, and application technique complicate clinical interpretation. This review aims to characterize reported PRP healing outcomes across dermatologically relevant cutaneous wound etiologies.
Methods
A literature search of PubMed, Embase, and SCOPUS (2020-2026) identified clinical studies and reviews evaluating platelet-derived therapies for cutaneous wound healing. We included studies that reported clinical healing outcomes after PRP treatment of cutaneous wounds. Studies without clinical wound-healing outcomes or evaluating noncutaneous tissue repair were excluded. Included studies were categorized as diabetic foot ulcers, venous leg ulcers, pressure ulcers, mixed chronic cutaneous ulcers, burns, or skin graft-related wounds. Healing outcomes were descriptively synthesized by etiology.
Results
Across chronic cutaneous wounds, PRP improved wound closure and wound-area reduction compared with conventional care. Evidence was strongest for DFUs, where PRP increased healing rates, shortened healing time, and accelerated ulcer-area reduction; several analyses also reported reduced amputation and hospitalization. In VLUs, topical platelet gel and injectable PRP improved healing scores and granulation tissue. In pressure ulcers, PRP alone or with negative-pressure wound therapy improved wound characteristics, shortened healing time, reduced pain, and decreased complications. Meta-analyses of mixed chronic wounds demonstrated increased complete closure, including an odds ratio of 5.32 in an analysis of 2,198 wounds. PRP did not generally increase infection or adverse-event rates. Burn and skin graft-related studies demonstrated accelerated epithelialization, improved graft uptake, and reduced postoperative pain. Treatment effects varied by PRP formulation, concentration, administration route, wound characteristics, and follow-up.
Conclusion
PRP demonstrates potential as an adjunctive regenerative therapy across multiple cutaneous wound etiologies, with the most consistent evidence supporting its use in chronic ulcers, particularly DFUs. Improvements are most consistently observed in wound closure, wound-area reduction, and healing time, with additional benefits reported for pain, hospitalization, and amputation risk. Heterogeneity in PRP preparation, dosing, administration, and outcome reporting remains a major barrier to standardized clinical application. Future dermatologic wound-healing studies should prioritize standardized PRP protocols and etiology-specific outcomes to better define optimal candidates and treatment strategies.
Zitieren
APA
Mendez, C., MS, Nguyen, N., DO, Lam, W., DO, MPH, Nestor, M. S., MD, & PhD (2026). Platelet-Rich Plasma for Cutaneous Wound Healing: Clinical Outcomes Across Wound Etiologies. SKIN The Journal of Cutaneous Medicine, 10(6), s819. https://doi.org/10.25251/0mchk561
Vancouver
Mendez C, MS, Nguyen N, DO, Lam W, DO, et al. Platelet-Rich Plasma for Cutaneous Wound Healing: Clinical Outcomes Across Wound Etiologies. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s819. doi:10.25251/0mchk561
BibTeX
@article{Mendez2026,
author = {Mendez, Christopher and MS and Nguyen, Ngoc and DO and Lam, Wilhelmina and DO and MPH and Nestor, Mark S. and MD and PhD},
title = {Platelet-Rich Plasma for Cutaneous Wound Healing: Clinical Outcomes Across Wound Etiologies},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s819},
doi = {10.25251/0mchk561}
}
EUVIMED